Immunicon Corporation is Considering Strategic Alternatives
April 7, 2008
HUNTINGDON VALLEY, Pa.--Immunicon Corporation (NASDAQ:IMMC - News) announced today that it is exploring and evaluating various financial and strategic alternatives for the Company, including the sale of some or all of its businesses. Immunicon has retained Stifel, Nicolaus & Company as its financial advisor to assist in exploring and evaluating various financial and strategic alternatives [...]
Oxford Instruments plc: Disposal of holding in Oxford Diffraction Limited.
April 7, 2008
Oxford Instruments plc ('Oxford Instruments'), the high technology tools and systems company, today announces the disposal of its 23% holding in Oxford Diffraction Limited ('Oxford Diffraction') to Varian, Inc. for a cash consideration of £3.5m. An additional cash amount of up to £1.1m may be received over the next three years conditional on the performance [...]
April 3, 2008
Tripos receives U.S. Patent protection and approval for innovative Topomer technologies; Topomer tools now linked for even more powerful compound searches ST. LOUIS--Tripos International, leading provider of drug discovery informatics products and services, today announced the availability of integrated versions of its recently patented Topomer Search and Topomer CoMFA® technologies. Tripos’ Topomer technologies accelerate the [...]
April 3, 2008
Allows researchers to assess small samples in high throughput qPCR PENZBERG, Germany & SAN CARLOS, Calif.--Roche Applied Science and NuGEN Technologies, Inc., a privately held company that develops and commercializes highly sensitive nucleic acid amplification and labeling systems, announced today an agreement that will enable Roche to market and sell an RNA amplification product based [...]
Sequenom Updates 2008 Financial Guidance
April 3, 2008
SAN DIEGO--Sequenom, Inc. (NASDAQ:SQNM - News), a leading provider of genetic analysis solutions, today updated its 2008 financial guidance. Revenues for the first quarter of 2008 will exceed revenues for the first quarter of 2007; however, while sales of MassARRAY® systems in Europe and the rest of the world were in line with expectations, sales [...]
Axela, Inc. Expands Board of Directors to Support Growth
April 3, 2008
TORONTO--Axela Inc., a recognized innovator in protein interaction technology, announced today it has expanded its Board of Directors as the company positions itself for growth in the diagnostic, life science, and pharmaceutical research markets. Joining Axela’s board are Dave Lemus, David Giddings, and Bill Clarke, MD. The new board members have a strong background in [...]
April 3, 2008
GRAND RAPIDS, Mich.--X-Rite, Incorporated, (NASDAQ: XRIT - News) a global leader in color technology, today provided an update regarding its first quarter 2008 revenue expectations based on weaker economic conditions and market specific softness that have adversely affected revenues during the period. Concurrently, the Company announced that it is implementing plans expected to result in [...]
Helicos BioSciences Announces Single Molecule DNA Sequence Data Published in Science Magazine
April 3, 2008
Data Validates the World’s First Single Molecule Sequencing of an Organism CAMBRIDGE, Mass.--Helicos BioSciences (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced the publication of a report in Science Magazine demonstrating the first single molecule sequencing of an organism. The report depicts the use of Helicos’ proprietary True Single [...]
Live-Cell, Real-Time Monitoring of cAMP Kinetics with Promega GloSensor™ Technology
April 3, 2008
MADISON, Wis.--Promega Corporation announces the launch of a breakthrough cell-based biosensor technology, termed GloSensor™ Technology. The non-lytic, live-cell GloSensor cAMP Assay is the first application of the patent-pending technology, which features a genetically engineered form of firefly luciferase. The benefit to screeners and scientists alike will be more biologically relevant data captured directly from living [...]
Caliper Life Sciences Appoints Peter F. McAree Senior Vice President and Chief Financial Officer
April 3, 2008
Joseph H. Griffith IV Promoted to Vice President of Finance HOPKINTON, Mass., April 3, 2008 -- Caliper Life Sciences, Inc. (Nasdaq: CALP - News) today announced the promotion of Peter F. McAree to Senior Vice President and Chief Financial Officer. McAree previously served as Vice President of Finance at Caliper. Effective April 4, Thomas Higgins [...]

